Galileo Research Facts No. 91: Can Galileo Therapy decrease Creatine Kinase levels in Duchenne (DMD) patients?
GRFS, Kids-Therapy

Galileo Research Facts No. 91: Can Galileo Therapy decrease Creatine Kinase levels in Duchenne (DMD) patients?

This study shows the effect of Galileo Therapy on Creatine Kinase (CK) levels in Duchenne Patients (5-20Hz, 2*1 to 2*2 min., 3/week, 12 weeks). Over a period of 3 months the CK levels dropped essentially by 98% and increases again after the end of the therapy period. CK is believed to indicate the amount of muscle fiber damage due to extensive muscle activity and therefore should be kept low in Duchenne patients...
Continue reading
Galileo Research Facts No. 73: Does Galileo Therapy increase Creatine Kinase levels in Duchenne patients?
GRFS, Kids-Therapy

Galileo Research Facts No. 73: Does Galileo Therapy increase Creatine Kinase levels in Duchenne patients?

This pilot study tested the effects of Galileo Therapy on Creatine Kinase (CK) levels in children with Duchenne Muscle Dystrophy (DMD, Age 4-14). (Flexed legs, 13-20Hz, pos. 2, 2*2 min., 3/week, 4 weeks). Galileo Training did not show any significant increases in CK levels during the 4 weeks of Galileo Therapy. This study shows a relevant safety aspect of Galileo Therapy for DMD patients...
Continue reading